Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.54 USD | -0.22% | +1.87% | -22.94% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company benefits from high valuations in earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.94% | 3.19B | B- | ||
-6.21% | 180B | C+ | ||
-0.08% | 108B | C | ||
-3.09% | 68.29B | A | ||
-4.84% | 46.96B | B- | ||
+12.85% | 45.64B | B- | ||
+7.77% | 42.41B | B+ | ||
+19.71% | 31.01B | B | ||
+16.55% | 25.51B | A- | ||
-7.44% | 23.17B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NVST Stock
- Ratings Envista Holdings Corporation